Show Summary Details
Page of

Genomic Applications in Audiological Medicine 

Genomic Applications in Audiological Medicine
Genomic Applications in Audiological Medicine

Daphne Karfunkel-Doron

, Zippora Brownstein

, and Karen B. Avraham

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 30 October 2020

Hearing loss (HL) is the most predominant sensorineural disorder, with an estimated genetic etiology of between 60-70% worldwide. Audiological or audiovestibular medicine is the medical specialty concerned with the diagnosis and management of audiovestibular and communication disorders, affecting individuals of all ages. Auditory disorders comprise a broad scope of etiologies that may be inherited, infectious, inflammatory, vascular, traumatic or metabolic. Current genomic tools available to health practitioners today facilitate a practical clinical approach for patients with hereditary HL. This approach will facilitate more precise clinical genetic diagnosis and improved patient care through rapid diagnosis, appropriate genetic counseling and proper medical management for auditory disorders. It is anticipated that genetic testing will become a standard clinical approach following a patient history, physical exam and audiometric profiling for hearing impaired patients.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.